CONSOLIDATED ENTITIES AND ACQUISITIONS - La Jolla Pharmaceutical Company (Details) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended		12 Months Ended
	Aug. 22, 2022	Aug. 31, 2023	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Change in inventory				$ 12,004	$ (280)	$ 0
La Jolla Pharmaceutical Company
Business Acquisition [Line Items]
Total consideration paid	$ 206,600
Acquisition share price	$ 6.23
Measurement period adjustments for change in value of goodwill		$ 3,000	$ (13,100)		3,700
Increase (decrease) in deferred tax assets		(2,400)	10,500
Change in inventory					(7,700)
Measurement period adjustments for change in value of intangible assets					(1,500)
Measurement period adjustments increase decrease in liabilities					(8,300)
Acquisition-related costs					5,300
Increase (decrease) in deferred tax liabilities		$ 600	$ (2,600)		$ 2,600